Company Profile

O2M Technologies LLC
Profile last edited on: 5/14/18      CAGE: 7TUN7      UEI: RLM1GHQF3MM6

Business Identifier: Oxygen imaging for enhanced therapies
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2242 West Harrison Street Suite 201-18
Chicago, IL 60612
   (773) 910-8533
Location: Single
Congr. District: 07
County: Cook

Public Profile

O2M Technologies is a preclinical stage medical device company developing novel magnetic resonance oxygen imaging instrumentation and methodologies for cancer radiation treatment targeting. With the O2M team including practicing oncologists and imaging professionals with expertise in cancer biology, instrumentation and software development, O2M specifically uses oxygen information specifically to attack radiation resistant cancer tissues and avoid unnecessary damage to other areas which reduces post-treatment complications and improves cancer treatment success.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $400,000
Project Title: Building The World's First Clinical Oxygen Imager For Efficient Cancer Treatment
2021 2 NSF $1,207,676
Project Title: Robust Bench-Top Oxygen Imager for Tissue Graft Viability Assessment
2020 2 NIH $2,613,595
Project Title: Robust Small Animal Oxygen Imager to Model Enhanced Cancer Treatment
0 1 NIH $400,000
Project Title: Methods for Fast and Efficient Oxygen Imaging

Key People / Management

  Howard J Halpern -- President

  Mrignayani Kotecha -- Co-Founder and CEO

  Boris Epel -- Chief Technology Officer

Company News

There are no news available.